Product Information
EMTRICITABINE-RILPIVIRINE-TENOFOVIR DIS FUM 200-25-300 MG TB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $114.9924 per EA under NDC 00378544093. Its NADAC has been published 19 times since Feb 18, 2026.
EMTRICITABINE-RILPIVIRINE-TENOFOVIR DIS FUM 200-25-300 MG TB
Emtricitabine, Rilpivirine, Tenofovir Disoproxil FumarateStrength
200; 25; 300 mg/1; mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378544093
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA208452On Market Since
5/27/2025
Pharmacological Classes
Price Statistics
The NADAC for EMTRICITABINE-RILPIVIRINE-TENOFOVIR DIS FUM 200-25-300 MG TB has been published 19 times since Feb 18, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $114.9924 per EA |
|---|---|
| All-time high | $114.9924 (Jun 24, 2026) |
| All-time low | $114.8597 (Feb 18, 2026) |
| 52-week high | $114.9924 |
| 52-week low | $114.8597 |
| Median price | $114.9924 |
| Average price | $114.9295 |
| Largest weekly change | +0.1% (Apr 22, 2026) |
| Weeks tracked | 19 |
| Tracking since | Feb 18, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of EMTRICITABINE-RILPIVIRINE-TENOFOVIR DIS FUM 200-25-300 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for EMTRICITABINE-RILPIVIRINE-TENOFOVIR DIS FUM 200-25-300 MG TB, manufactured by Mylan Pharmaceuticals Inc., is $114.9924 per EA (NDC 00378544093), effective Jun 24, 2026.
How has the price of EMTRICITABINE-RILPIVIRINE-TENOFOVIR DIS FUM 200-25-300 MG TB changed over time?
Over the history we have for it, the NADAC for EMTRICITABINE-RILPIVIRINE-TENOFOVIR DIS FUM 200-25-300 MG TB has held within roughly two percent of its current level. It has been tracked across 19 weekly CMS publications since Feb 18, 2026.
What are the highest and lowest recorded NADAC prices for EMTRICITABINE-RILPIVIRINE-TENOFOVIR DIS FUM 200-25-300 MG TB?
Since Feb 18, 2026, the NADAC for EMTRICITABINE-RILPIVIRINE-TENOFOVIR DIS FUM 200-25-300 MG TB has ranged from a low of $114.8597 (Feb 18, 2026) to a high of $114.9924 (Jun 24, 2026), with a median of $114.9924 per EA.
Are there cheaper alternatives to EMTRICITABINE-RILPIVIRINE-TENOFOVIR DIS FUM 200-25-300 MG TB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of EMTRICITABINE-RILPIVIRINE-TENOFOVIR DIS FUM 200-25-300 MG TB, so no direct lower-cost alternative is listed.
Who manufactures EMTRICITABINE-RILPIVIRINE-TENOFOVIR DIS FUM 200-25-300 MG TB?
EMTRICITABINE-RILPIVIRINE-TENOFOVIR DIS FUM 200-25-300 MG TB (NDC 00378544093) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification